Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001556581 | SCV001778190 | likely benign | not provided | 2021-04-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001556581 | SCV002063113 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | CHD8: PP2, BS1 |
Ambry Genetics | RCV002343731 | SCV002652683 | likely benign | Inborn genetic diseases | 2019-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001556581 | SCV003023680 | uncertain significance | not provided | 2024-08-11 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1828 of the CHD8 protein (p.Arg1828His). This variant is present in population databases (rs199908540, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with neurodevelopmental disorder (PMID: 33004838). This variant is also known as c.5507G>A (p.Arg1836His). ClinVar contains an entry for this variant (Variation ID: 1193997). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CHD8 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |